Singapore: Trendlines rights issue at 19.3% premium to share price

Steve Rhodes, chairman and chief executive, Trendlines

SGX-listed Israeli medical and agricultural technology incubator Trendlines has taken the unusual step of trying to raise capital at an enthusiastic premium to where its shares are currently trading. Most companies announce that they are raising capital a discount to the current share price to attract investor interest. Called on the move by the SGX,…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »